To get approval in India, vaccines must work in at least 50% cases

​​ The vaccine that will go for approval must elicit superior immune responses compared to no vaccination against Covid-19, the guidelines said. An individual who gets the vaccine should be protected from reinfection for at least a year.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3iUoyrE
via IFTTT